The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Table 7.15

Cancer of the Corpus and Uterus, NOS (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2016
By Race/Ethnicity and Years Since Diagnosis

Race/Ethnicity Years Since Diagnosis Completee
0 to <5 5 to <10 10 to <15 15 to <20 20 to <24 0 to <24b >=24d
All Races 225,923 161,291 116,320 86,194 46,958 636,687 135,558 772,245
White 190,505 140,678 103,752 78,371 43,211 556,518 115,722 677,802
Black 21,411 11,777 7,015 4,029 1,919 46,152 5,451 51,603
Asian/Pacific Islander 9,979 6,356 4,242 2,678 1,383 24,638 + +
Hispanic 20,762 11,784 8,068 4,746 2,486 47,847 + +

Estimated prevalence percent a on January 1, 2016, of the SEER population diagnosed in the previous 24 years
By Age at Prevalence and Race/Ethnicity

Race/Ethnicity Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races 0.3892 0.0000 0.0001 0.0039 0.0359 0.1396 0.4412 1.1392 1.6248 1.4673 0.3031
White 0.4375 - 0.0001 0.0034 0.0362 0.1434 0.4620 1.2017 1.7198 1.5662 0.3190
Black 0.1967 0.0002 - 0.0052 0.0270 0.0948 0.2599 0.7780 1.1136 0.8228 0.1986
Asian/Pacific Islander 0.2323 - - 0.0055 0.0360 0.1543 0.4831 0.8547 0.8978 0.6922 0.2210
Hispanic 0.1694 - - 0.0056 0.0520 0.1565 0.3945 0.8469 1.0561 0.7990 0.2280

Footnotes:

a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2016 US population estimates based on the average of 2015 and 2016 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years.

b Maximum limited-duration prevalence is 24 years for 1992-2016 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing 0 to <24 and >=24.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.